Gubra ASSTU:PI3 +0.91%56 Forward Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus rates STU:PI3 with a GF Score™ of 56/100 and a GF Value™ of €381.59 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 146 Biotechnology companies, Gubra AS ranks worse than 684930.82% on this metric.
As of today (2026-06-26), the Forward Annual Dividend Yield of Gubra AS is 0.00%.
As of today (2026-06-26), the Trailing Annual Dividend Yield of Gubra AS is 0.00%.
STU:PI3's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.525 * Ranked among companies with meaningful Forward Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Gubra AS (STU:PI3) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
STU:PI3 vs VRTX, REGN, ALNY: Forward Dividend Yield % Comparison
For the Biotechnology subindustry, Gubra AS's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gubra AS Forward Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Gubra AS's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Gubra AS's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Gubra AS (STU:PI3) has a Forward Dividend Yield % of 0.00% as of Jun. 26, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Gubra AS and its competitors. According to the industry distribution chart, Gubra AS ranks #999999 out of 146 companies in the Biotechnology industry.
Is Gubra AS's Forward Dividend Yield % too high?
Gubra AS's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Gubra AS ranks #999999 out of 146 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Gubra AS has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gubra AS's Forward Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Gubra AS ranks #999999 out of 146 companies for Forward Dividend Yield %. This places Gubra AS in the lower half of its industry. The industry median Forward Dividend Yield % is 1.53. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.53, based on 146 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Gubra AS and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gubra AS's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gubra AS stock overvalued right now?
Based on GuruFocus' analysis, Gubra AS (STU:PI3) is currently considered Possible Value Trap. The stock's GF Value™ is €381.59, compared to a current price of €44.42 — trading 88.4% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Gubra AS's overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Gubra AS (STU:PI3), the current Forward Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gubra AS (STU:PI3) Overvalued in 2026?
Based on GuruFocus' analysis, Gubra AS stock appears to be undervalued.
The current stock price of €44.42 is trading 88.4% below its estimated GF Value™ of €381.59.
GuruFocus considers Gubra AS to be Possible Value Trap.
Key valuation signals for STU:PI3:
Forward Dividend Yield %: 0.00%
GF Value™: €381.59 vs. price of €44.42 (88.4% below fair value)
No single metric tells the full story. See the STU:PI3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has two segments: Pre-clinical contract research (CRO), which derives maximum revenue and Biotech Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.
56GF Score
Get the complete analysis for STU:PI3
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:PI3 has been successfully added to your 